Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Lifecore Biomedical Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lifecore Biomedical Inc. June 4, 2026100.0%
-
Lifecore Biomedical Inc. October 29, 202599.7%
-
Lifecore Biomedical Inc. November 7, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Palvella Therapeutics Inc. | Option exercise | +1,000 | $13.60 | $13,600 |
| Jun 4, 2026 | Lifecore Biomedical Inc. | Grant or award | +25,907 | — | — |
| Jul 15, 2025 | Lifecore Biomedical Inc. | Grant or award | +19,506 | — | — |
| Sep 23, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +395 | $49.99 | $19,746 |
| Sep 23, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +9,377 | $52.84 | $495,481 |
| Sep 23, 2024 | Ligand Pharmaceuticals Incorporated | Open-market sale | −2,481 | $100.05 | $248,224 |
| Sep 23, 2024 | Ligand Pharmaceuticals Incorporated | Open-market sale | −7,090 | $101.61 | $720,415 |
| Sep 23, 2024 | Ligand Pharmaceuticals Incorporated | Open-market sale | −201 | $102.05 | $20,512 |
| Sep 20, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +4,982 | $49.99 | $249,050 |
| Sep 20, 2024 | Ligand Pharmaceuticals Incorporated | Open-market sale | −6,275 | $104.10 | $653,228 |
| Sep 16, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +914 | $55.75 | $50,956 |
| Sep 16, 2024 | Ligand Pharmaceuticals Incorporated | Shares withheld for tax | −485 | $105.00 | $50,925 |
| Sep 16, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +849 | $58.49 | $49,658 |
| Sep 16, 2024 | Ligand Pharmaceuticals Incorporated | Shares withheld for tax | −472 | $105.00 | $49,560 |
| Sep 16, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +671 | $49.99 | $33,543 |
Questions about Matthew E. Korenberg
What boards is Matthew E. Korenberg on?
Matthew E. Korenberg sits on the board of Lifecore Biomedical Inc.
How long has Matthew E. Korenberg served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.